Blueprint’s most recently approved drug is Ayvakit, which the US Food and Drug Administration approved in 2020 to treat gastrointestinal…
Read More
Blueprint’s most recently approved drug is Ayvakit, which the US Food and Drug Administration approved in 2020 to treat gastrointestinal…
Read More